DYNE-302

N/A

Report date: 2024/12/26 17:39:22

Base Information

Drug NameDYNE-302
Drug Alias NameDYNE-302DYNE302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionTransferrin receptor protein 1 bindersDouble homeobox protein 4 inhibitors
TargetsTransferrin receptor protein 1Double homeobox protein 4
Therapy Area/IndicationsMuscular Dystrophy, Facioscapulohumeral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDyne Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDyne Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Facioscapulohumeral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A